Etamsylate

BLOOD AND BLOOD FORMING ORGANS

Key facts

Etamsylate is a drug catalogued in DrugCentral.

• ATC code: B02BX01 (Other systemic hemostatics).
• Molecular formula: C10H17NO5S; molecular weight 263.31 g/mol.

ATC classification

ATC code	Therapeutic hierarchy
B02BX01	BLOOD AND BLOOD FORMING ORGANS › ANTIHEMORRHAGICS › VITAMIN K AND OTHER HEMOSTATICS › Other systemic hemostatics

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA term	LLR
Platelet count decreased	59.5
Anaemia	58.8
Negative symptoms in schizophrenia	56.4
Neutrophil count decreased	43.0
Oligohydramnios	41.4
Myelosuppression	40.3
Thrombocytopenia	39.0
Leukopenia	38.8
Distractibility	36.4

Chemical structure

• Molecular formula: C₁₀H₁₇NO₅S
• Molecular weight: 263.31 g/mol
• CAS number: 2624-44-4
• InChIKey: —
• PubChem CID: 17506

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is the chemical formula of Etamsylate?

Etamsylate has the molecular formula C10H17NO5S and a molecular weight of 263.31 g/mol.

Sources

• DrugCentral drug card 1075 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL1514715 — compound record and bioactivity
• PubChem CID 17506 — chemical identifiers
• DrugBank DB13483 — drug record
• FDA UNII 24YL531VOH — substance identity
• FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral

How this page is built: methodology · editorial policy & corrections.